BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 24141962)

  • 1. Decreased memory T-cell response and function in human immunodeficiency virus-infected patients with tegumentary leishmaniasis.
    Gois LL; Mehta S; Rodrigues MZ; Schooley RT; Badaró R; Grassi MF
    Mem Inst Oswaldo Cruz; 2014 Feb; 109(1):9-14. PubMed ID: 24141962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunologic response and memory T cells in subjects cured of tegumentary leishmaniasis.
    Carvalho AM; Magalhães A; Carvalho LP; Bacellar O; Scott P; Carvalho EM
    BMC Infect Dis; 2013 Nov; 13():529. PubMed ID: 24206576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCR7+ central and CCR7- effector memory CD4+ T cells in human cutaneous leishmaniasis.
    Keshavarz Valian H; Nateghi Rostami M; Tasbihi M; Miramin Mohammadi A; Eskandari SE; Sarrafnejad A; Khamesipour A
    J Clin Immunol; 2013 Jan; 33(1):220-34. PubMed ID: 22990666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic and Functional Profiles of Antigen-Specific CD4
    Egui A; Ledesma D; Pérez-Antón E; Montoya A; Gómez I; Robledo SM; Infante JJ; Vélez ID; López MC; Thomas MC
    Front Cell Infect Microbiol; 2018; 8():393. PubMed ID: 30510917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The skin homing receptor cutaneous leucocyte-associated antigen (CLA) is up-regulated by Leishmania antigens in T lymphocytes during active cutaneous leishmaniasis.
    Mendes-Aguiar Cde O; Gomes-Silva A; Nunes E; Pereira-Carvalho R; Nogueira RS; Oliveira-Neto Mde P; Bertho AL; Da-Cruz AM
    Clin Exp Immunol; 2009 Sep; 157(3):377-84. PubMed ID: 19664146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design of multi-epitope peptides containing HLA class-I and class-II-restricted epitopes derived from immunogenic Leishmania proteins, and evaluation of CD4+ and CD8+ T cell responses induced in cured cutaneous leishmaniasis subjects.
    Hamrouni S; Bras-Gonçalves R; Kidar A; Aoun K; Chamakh-Ayari R; Petitdidier E; Messaoudi Y; Pagniez J; Lemesre JL; Meddeb-Garnaoui A
    PLoS Negl Trop Dis; 2020 Mar; 14(3):e0008093. PubMed ID: 32176691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dominant enrichment of phenotypically activated CD38(+) HLA-DR(+) CD8(+) T cells, rather than CD38(+) HLA-DR(+) CD4(+) T cells, in HIV/HCV coinfected patients on antiretroviral therapy.
    d'Ettorre G; Ceccarelli G; Serafino S; Giustini N; Cavallari EN; Bianchi L; Pavone P; Bellelli V; Turriziani O; Antonelli G; Stroffolini T; Vullo V
    J Med Virol; 2016 Aug; 88(8):1347-56. PubMed ID: 26765625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating the impact of hepatitis C virus (HCV) on highly active antiretroviral therapy-mediated immune responses in HCV/HIV-coinfected women: role of HCV on expression of primed/memory T cells.
    Al-Harthi L; Voris J; Du W; Wright D; Nowicki M; Frederick T; Landay A; Kovacs A
    J Infect Dis; 2006 May; 193(9):1202-10. PubMed ID: 16586355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flow cytometric determination of cellular sources and frequencies of key cytokine-producing lymphocytes directed against recombinant LACK and soluble Leishmania antigen in human cutaneous leishmaniasis.
    Bottrel RL; Dutra WO; Martins FA; Gontijo B; Carvalho E; Barral-Netto M; Barral A; Almeida RP; Mayrink W; Locksley R; Gollob KJ
    Infect Immun; 2001 May; 69(5):3232-9. PubMed ID: 11292745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical, immunological and treatment-related factors associated with normalised CD4+/CD8+ T-cell ratio: effect of naïve and memory T-cell subsets.
    Tinago W; Coghlan E; Macken A; McAndrews J; Doak B; Prior-Fuller C; Lambert JS; Sheehan GJ; Mallon PW;
    PLoS One; 2014; 9(5):e97011. PubMed ID: 24816636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD45RO+ T Cells and T Cell Activation in the Long-Lasting Immunity after
    Rodrigues-Neto JF; Monteiro GR; Keesen TSL; Lacerda HG; Carvalho EM; Jeronimo SMB
    Am J Trop Med Hyg; 2018 Mar; 98(3):875-882. PubMed ID: 29280433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD8+ T cells as a source of IFN-γ production in human cutaneous leishmaniasis.
    Nateghi Rostami M; Keshavarz H; Edalat R; Sarrafnejad A; Shahrestani T; Mahboudi F; Khamesipour A
    PLoS Negl Trop Dis; 2010 Oct; 4(10):e845. PubMed ID: 20967288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of human T lymphocyte-mediated immune responses induced by a vaccine against American tegumentary leishmaniasis.
    Mendonca SC; De Luca PM; Mayrink W; Restom TG; Conceicao-Silva F; Da-Cruz AM; Bertho AL; Da Costa CA; Genaro O; Toledo VP
    Am J Trop Med Hyg; 1995 Aug; 53(2):195-201. PubMed ID: 7677224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphoproliferative response after stimulation with soluble leishmania antigen (SLA) as a predictor of visceral leishmaniasis (VL) relapse in HIV+ patients.
    Castro A; Carrillo E; San Martín JV; Botana L; Molina L; Matía B; Fernandez L; Horrillo L; Ibarra-Meneses A; Sanchez C; Ruiz-Giardin JM; Moreno J
    Acta Trop; 2016 Dec; 164():345-351. PubMed ID: 27693332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired T-cell-dependent protection against Leishmania major infection in HIV-positive patients is associated with worsened disease outcome.
    Ngouateu OB; Weller K; Bröhl K; Kamtchouing P; Same-Ekobo A; Dondji B; Maurer M; von Stebut E
    Exp Dermatol; 2015 Apr; 24(4):302-4. PubMed ID: 25651477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flow cytometric analysis of cellular infiltrate from American tegumentary leishmaniasis lesions.
    Da-Cruz AM; Bertho AL; Oliveira-Neto MP; Coutinho SG
    Br J Dermatol; 2005 Sep; 153(3):537-43. PubMed ID: 16120139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-cell responsiveness of American cutaneous leishmaniasis patients to purified Leishmania pifanoi amastigote antigens and Leishmania braziliensis promastigote antigens: immunologic patterns associated with cure.
    Coutinho SG; Oliveira MP; Da-Cruz AM; De Luca PM; Mendonça SC; Bertho AL; Soong L; McMahon-Pratt D
    Exp Parasitol; 1996 Nov; 84(2):144-55. PubMed ID: 8932764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of Leishmania braziliensis antigen-specific CD4+ T, CD8+ T, NK and CD3+CD56+NKT cells in the immunopathogenesis of cutaneous leishmaniasis patients: Cytotoxic, activation and exhaustion profiles.
    Cunha CF; Ferraz-Nogueira R; Costa VFA; Pimentel MIF; Chometon TQ; Lyra MR; Schubach AO; Da-Cruz AM; Bertho AL
    PLoS One; 2020; 15(3):e0229400. PubMed ID: 32203546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effector memory CD4(+) T cells differentially express activation associated molecules depending on the duration of American cutaneous leishmaniasis lesions.
    de Oliveira Mendes-Aguiar C; Vieira-Gonçalves R; Guimarães LH; de Oliveira-Neto MP; Carvalho EM; Da-Cruz AM
    Clin Exp Immunol; 2016 Aug; 185(2):202-9. PubMed ID: 27059407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HCV-specific T-cell responses in HIV/hepatitis C virus-coinfected patients on highly active antiretroviral therapy are comparable to those observed in hepatitis C virus-monoinfected individuals.
    Rallón NI; Soriano V; Restrepo C; García-Samaniego J; Labarga P; López M; Peris A; González-Lahoz J; Benito JM
    J Acquir Immune Defic Syndr; 2011 May; 57(1):1-8. PubMed ID: 21786458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.